Go offline with the Player FM app!
Ep 96: The Menopause-Alzheimer's Connection: Why Timing Matters for Women's Brain Health with Dr. Rachel Buckley (part 2)
Manage episode 514962110 series 41856
BrainStorm wants to hear from you! Send us a text.
Dr. Rachel Buckley discusses the critical link between menopause and Alzheimer's risk in women with BrainStorm host Meryl Comer. Dr. Buckley explains that early menopause can be associated with faster cognitive decline and higher tau levels in the brain. She emphasizes the importance of timing for hormone replacement therapy and how estrogen plays a vital role in brain health through receptors that regulate communication between brain regions and mood. Dr. Buckley advocates for proactive conversations with doctors starting at age 40, midlife cognitive checkups around age 55, and better sex-specific reporting in clinical trials, noting that recent Alzheimer's treatments showed dramatically different results in men (42% benefit) versus women (12% benefit). As leader of a Welcome LEAP research team, she's working to cut women's lifetime Alzheimer's risk in half within three years, representing a new wave of prevention-focused research that coincides with the critical menopause transition period. This is a must listen episode!
60 episodes
Manage episode 514962110 series 41856
BrainStorm wants to hear from you! Send us a text.
Dr. Rachel Buckley discusses the critical link between menopause and Alzheimer's risk in women with BrainStorm host Meryl Comer. Dr. Buckley explains that early menopause can be associated with faster cognitive decline and higher tau levels in the brain. She emphasizes the importance of timing for hormone replacement therapy and how estrogen plays a vital role in brain health through receptors that regulate communication between brain regions and mood. Dr. Buckley advocates for proactive conversations with doctors starting at age 40, midlife cognitive checkups around age 55, and better sex-specific reporting in clinical trials, noting that recent Alzheimer's treatments showed dramatically different results in men (42% benefit) versus women (12% benefit). As leader of a Welcome LEAP research team, she's working to cut women's lifetime Alzheimer's risk in half within three years, representing a new wave of prevention-focused research that coincides with the critical menopause transition period. This is a must listen episode!
60 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.